Your session is about to expire
← Back to Search
Physiological Monitor
Perioperative Monitoring with Vitalstream for Low Cardiac Output
N/A
Recruiting
Led By Ashish Khanna, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients (age > 18) admitted to the Intensive Care Unit (ICU) with a pulmonary artery catheter (continuous or intermittent thermodilution cardiac output) and an arterial catheter for Blood Pressure (BP) monitoring (standard of care)
Adult post-cardiac surgery needing cardiopulmonary bypass and use of the pulmonary artery catheter (PAC) as standard of care, (s/p coronary artery bypass graft (CABG), valve, heart transplant, major aortic & other vascular surgery, and a combination of CABG and valve procedures)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up hour 24
Awards & highlights
Study Summary
This trial tests the accuracy of a device that measures heart rate, BP, resp. rate, stroke volume & cardiac output, compared to a Gold Standard.
Who is the study for?
This trial is for adults over 18 in the ICU after cardiac surgery who need a pulmonary artery catheter and arterial BP monitoring. It's not for patients with left ventricular assist devices or those without a properly placed or working pulmonary artery catheter post-surgery.Check my eligibility
What is being tested?
The study tests Vitalstream, a noninvasive monitor that measures heart rate, blood pressure, respiratory rate, stroke volume, and cardiac output against standard thermodilution methods used in intensive care.See study design
What are the potential side effects?
Since Vitalstream is a monitoring device rather than a medication or invasive procedure, it's expected to have minimal side effects related to its use on the skin or possible discomfort from wearing the device.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 18, in the ICU, and have catheters for heart and BP monitoring.
Select...
I had heart surgery requiring a heart-lung machine and a special heart monitoring catheter.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ hour 24
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~hour 24
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Blood pressure values
Cardiac output values
Other outcome measures
Assessment of fluid responsiveness changes
Trial Design
1Treatment groups
Experimental Treatment
Group I: VitalstreamExperimental Treatment1 Intervention
Device placed on the subject preoperatively in the holding room and continued postoperatively into the Cardiac Intensive Care Unit (ICU).
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,243 Previous Clinical Trials
1,004,684 Total Patients Enrolled
Ashish Khanna, MDPrincipal InvestigatorWake Forest University Health Sciences
2 Previous Clinical Trials
1,050 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am over 18, in the ICU, and have catheters for heart and BP monitoring.I had heart surgery requiring a heart-lung machine and a special heart monitoring catheter.You are currently using a left ventricular assist device (LVAD) for heart support.I don't have a working lung artery catheter after heart surgery.
Research Study Groups:
This trial has the following groups:- Group 1: Vitalstream
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is it still possible to sign up for this research endeavor?
"Unfortunatley, the clinicaltrials.gov website states that this trial is not actively seeking patients at present. It was first posted on June 1st 2023 and last updated on the 7th of the same month. Fortunately, there are 6 other studies currently recruiting participants to join them."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger